Welcome! If you have any pricing inquiries, please don't hesitate to reach out to us using the form on the left side. We'll respond to you promptly.
CD Formulation specializes in tailoring ionizable lipids to meet the unique needs of our clients. With integrated expertise in lipid chemistry, analytical characterization, formulation development and preclinical testing, we offer comprehensive customization options to optimize key properties like transfection efficiency, pharmacokinetics, and scalability.
Ionizable lipids can respond to pH changes in endosomes or lysosomes, converting from a neutral state to a positively charged state in an acidic environment. Ionizable lipids in their neutral state are relatively stable and can be formulated and stored efficiently. Positively charged ionizable lipids promote cellular uptake and endosomal escape.
Molecular structures and component segments of ionizable lipids (Xu Y.; et al. 2023)
CD Formulation has extensive experience in the development of ionizable polymer-lipids, which enhance particle formation and exhibit a preference for transfecting specific cell populations. We specialize in addressing the complexity of these lipids and overcoming the challenges associated with toxic polycation cores and non-degradable backbones.
We use strategies such as ester and disulfide bonds to enhance biodegradability, optimize the balance between activity and degradation, and meet the critical need to reduce side effects and accumulation. Through careful synthesis and formulation, we are able to efficiently deliver RNA therapeutics, ASOs, and CRISPR/Cas9 systems.
We can customize advanced branched-tail ionizable lipids for targeted mRNA delivery applications. Through medicinal chemistry and screening, we develop novel lipids containing branches near the headgroup or at the end of tails to optimize transfection activity and hepatocyte targeting.
In order to enhance gene delivery, we develop unsaturated ionizable lipids with varying fluidity and efficacy. As experts in designing and testing these lipids, we ensure effective therapeutic outcomes by optimizing membrane disruption, payload release, and in vivo RNA delivery.
Our ionizable lipids can enhance mRNA delivery and protein expression for the development of more effective vaccines, leveraging the immune activation of self-amplifying mRNA constructs.
We customize ionizable lipids to optimize the efficiency and performance of lipid nanoparticle formulations, supporting the delivery of a variety of small molecule and biologic therapeutics.
Our ionizable lipids enable efficient intracellular transport of genes, gene editing tools, and oligonucleotides, facilitating applications in gene therapy through regulated expression, silencing, or genomic editing.
Our formulation expertise aids in developing ionizable lipids tailored for chimeric antigen receptor mRNA delivery and T-cell genetic modification, enhancing adoptive cellular immunotherapy approaches.
Contact us today to discuss how we can leverage our formulation expertise to help you achieve your research and therapeutic goals! Our scientists are ready to collaborate and advance your lipid-based delivery technology.
References